Levemir can cost $350-$500 without insurance. Learn how to save with coupons, discount cards, patient assistance programs, and other tips in 2026.
Let's be honest: insulin in the United States is expensive. And Levemir (Insulin Detemir) is no exception. Without insurance, a single box of 5 Levemir FlexTouch pens can cost between $350 and $500. A 10 mL vial runs about the same. For patients who need insulin every day to stay alive, that cost adds up fast.
Making matters worse, Novo Nordisk is discontinuing Levemir, which means finding it is already a challenge (see our Levemir shortage update). If you do manage to find it, you want to pay as little as possible.
In this guide, we'll walk you through every way to save money on Levemir in 2026 — from coupons and discount cards to patient assistance programs and alternative strategies.
Here's what you can expect to pay at the pharmacy counter without insurance:
These prices can vary by pharmacy and region. As supply decreases due to the discontinuation, prices may become less predictable.
There is no generic or biosimilar version of Insulin Detemir, so there's no cheaper "generic" option for Levemir specifically. However, alternative long-acting insulins (covered below) may offer significant savings.
Prescription discount cards can reduce your out-of-pocket cost for Levemir, though availability and savings vary as the drug is being discontinued:
GoodRx aggregates prices across pharmacies and offers free coupons. Search for "Levemir" on goodrx.com to see current prices at pharmacies near you. Savings vary, but GoodRx has historically offered 10-20% off the cash price for Levemir.
SingleCare is another free discount card program accepted at most major pharmacies. Check singlecare.com for current Levemir pricing. SingleCare can sometimes offer better prices than GoodRx at certain pharmacies, so it's worth comparing.
RxSaver (rxsaver.com) compares discount prices across multiple pharmacies. Enter "Levemir" to see available coupons and pricing.
Optum Perks (perks.optum.com) is another discount platform that may offer savings on Levemir at participating pharmacies.
BuzzRx (buzzrx.com) offers free prescription discounts and may have competitive pricing for Levemir.
Important note: Discount cards cannot be combined with insurance. You use one or the other — whichever gives you the lower price. Ask your pharmacist to compare your insurance copay with the discount card price before paying.
Novo Nordisk previously offered a savings card through NovoCare that could reduce Levemir copays to as low as $25 per prescription for commercially insured patients. However, as Levemir is being discontinued, this program may no longer be active. Check novocare.com or call 1-866-310-7549 to verify current availability.
For patients without insurance who meet income requirements (generally household income at or below 400% of the federal poverty level), Novo Nordisk's Patient Assistance Program may provide Levemir at no cost. To apply:
Even with the discontinuation, the PAP may continue to operate for as long as Levemir inventory exists.
Beyond Novo Nordisk's own programs, several nonprofit organizations help patients access insulin:
NeedyMeds maintains a database of patient assistance programs, discount drug programs, and disease-based assistance programs. Search for "Levemir" or "Insulin Detemir" to find current options.
RxAssist is a comprehensive database of pharmaceutical company patient assistance programs. It can help you identify programs for both Levemir and its alternatives.
RxHope provides a single-source application portal for many manufacturer patient assistance programs, simplifying the application process.
GetInsulin.org, run by the nonprofit Beyond Type 1, helps people with diabetes access affordable insulin through emergency programs and advocacy resources.
If Levemir is too expensive or too hard to find, switching to an alternative long-acting insulin can save you significant money:
Talk to your doctor about whether one of these alternatives is right for you. For a detailed comparison, see our guide on alternatives to Levemir.
If you have Medicare Part D or certain commercial insurance plans, your out-of-pocket cost for many insulins is capped at $35 per month. This cap applies to most Insulin Glargine products, including Lantus, Basaglar, and Semglee. Ask your pharmacist or insurance company if this cap applies to your plan.
Filling a 90-day supply instead of 30 days can sometimes reduce your per-unit cost, especially through mail-order pharmacies. Ask your doctor to write your prescription for 90 days if your insurance or pharmacy allows it.
Some states have their own insulin affordability programs or emergency access provisions. Check with your state's department of health or insurance commissioner's office to see if additional assistance is available where you live.
Here's a quick strategy to make sure you're paying the lowest possible price for your insulin:
No one should have to choose between paying for insulin and paying for other necessities. While Levemir's cash price of $350 to $500 is steep, there are real ways to lower your costs — from discount cards and patient assistance programs to switching to a more affordable alternative insulin.
If you're struggling with the cost of Levemir or its alternatives, don't give up. Explore the resources in this guide, talk to your doctor about your options, and use Medfinder to find the best pharmacy prices and availability near you.
For more information about finding Levemir, see our guides on how to find Levemir in stock and how to find a doctor who can prescribe Levemir.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
